Molecular and neuroendocrine mechanisms of cancer cachexia
- PMID: 26112046
- DOI: 10.1530/JOE-15-0170
Molecular and neuroendocrine mechanisms of cancer cachexia
Abstract
Cancer and its morbidities, such as cancer cachexia, constitute a major public health problem. Although cancer cachexia has afflicted humanity for centuries, its underlying multifactorial and complex physiopathology has hindered the understanding of its mechanism. During the last few decades we have witnessed a dramatic increase in the understanding of cancer cachexia pathophysiology. Anorexia and muscle and adipose tissue wasting are the main features of cancer cachexia. These apparently independent symptoms have humoral factors secreted by the tumor as a common cause. Importantly, the hypothalamus has emerged as an organ that senses the peripheral signals emanating from the tumoral environment, and not only elicits anorexia but also contributes to the development of muscle and adipose tissue loss. Herein, we review the roles of factors secreted by the tumor and its effects on the hypothalamus, muscle and adipose tissue, as well as highlighting the key targets that are being exploited for cancer cachexia treatment.
Keywords: cancer; hypothalamus; muscle; neuroendocrinology; neuropeptides.
© 2015 Society for Endocrinology.
Similar articles
-
Cytokines and cancer anorexia cachexia syndrome.Am J Hosp Palliat Care. 2008 Oct-Nov;25(5):407-11. doi: 10.1177/1049909108315518. Epub 2008 Apr 10. Am J Hosp Palliat Care. 2008. PMID: 18403577 Review.
-
[Systemic and local mechanisms leading to cachexia in cancer].Postepy Hig Med Dosw (Online). 2013 Dec 31;67:1397-409. doi: 10.5604/17322693.1085135. Postepy Hig Med Dosw (Online). 2013. PMID: 24493689 Review. Polish.
-
Energy metabolism in cachexia.EMBO Rep. 2019 Apr;20(4):e47258. doi: 10.15252/embr.201847258. Epub 2019 Mar 19. EMBO Rep. 2019. PMID: 30890538 Free PMC article. Review.
-
Regulation of adipose tissue metabolism in cancer cachexia.Curr Opin Clin Nutr Metab Care. 2008 May;11(3):201-7. doi: 10.1097/MCO.0b013e3282f948e2. Curr Opin Clin Nutr Metab Care. 2008. PMID: 18403913 Review.
-
Cachexia in cancer patients.Nat Rev Cancer. 2002 Nov;2(11):862-71. doi: 10.1038/nrc927. Nat Rev Cancer. 2002. PMID: 12415256 Review. No abstract available.
Cited by
-
Blocking muscle wasting via deletion of the muscle-specific E3 ubiquitin ligase MuRF1 impedes pancreatic tumor growth.Res Sq [Preprint]. 2023 Feb 9:rs.3.rs-2524562. doi: 10.21203/rs.3.rs-2524562/v1. Res Sq. 2023. Update in: Commun Biol. 2023 May 13;6(1):519. doi: 10.1038/s42003-023-04902-2. PMID: 36798266 Free PMC article. Updated. Preprint.
-
Establishment and characterization of a novel murine model of pancreatic cancer cachexia.J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):824-838. doi: 10.1002/jcsm.12225. Epub 2017 Jul 20. J Cachexia Sarcopenia Muscle. 2017. PMID: 28730707 Free PMC article.
-
FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness.J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):421-442. doi: 10.1002/jcsm.12666. Epub 2021 Feb 1. J Cachexia Sarcopenia Muscle. 2021. PMID: 33527776 Free PMC article.
-
Tumour-derived Dilp8/INSL3 induces cancer anorexia by regulating feeding neuropeptides via Lgr3/8 in the brain.Nat Cell Biol. 2021 Feb;23(2):172-183. doi: 10.1038/s41556-020-00628-z. Epub 2021 Feb 8. Nat Cell Biol. 2021. PMID: 33558728
-
Muscle strength and mass as predictors of pancreatic cancer: insights from the UK biobank.BMC Cancer. 2025 Aug 20;25(1):1346. doi: 10.1186/s12885-025-14766-w. BMC Cancer. 2025. PMID: 40836282 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources